Live Breaking News & Updates on Forschungszentrum Borstel

Stay updated with breaking news from Forschungszentrum borstel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

First-in-class oral antibiotic improves tuberculosis

First-in-class oral antibiotic improves tuberculosis
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

South Africa , Cape Town , Western Cape , Andreas Diacon , University Of Cape Town South Africa , University Of Troms , Foundation South Africa , Global Health Medicines Rd Spain , European Union Eu Horizon , Chief Scientific Officer , Confidence Interval , Forschungszentrum Borstel , European Union , Union World Conference , Lung Health ,

GSK's new type of TB drug shows bactericidal activity in phase 2 trial (NYSE:GSK)

GSK (GSK) said on Monday that its first-in-class once-daily oral medicine GSK3036656 was well tolerated and showed early bactericidal activity in people with drug-susceptible. ....

South Africa , Cape Town , Western Cape , United States , United Kingdom , Andreas Diacon , University Of Cape Town South Africa , University Of Troms , Foundation South Africa , Global Health Medicines Rd Spain , Forschungszentrum Borstel , Chief Scientific Officer ,

Launch of UNITE4TB partnership marks a new era in tuberculosis treatment development

Launch of UNITE4TB partnership marks a new era in tuberculosis treatment development
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , South Africa , Stichting Radboud Universitair Medisch , Le Developpement , Pierre Meulien , Glaxosmithkline Investigaci , Deutsches Zentrum , Forschungszentrum Borstel , Anja Karliczek , Lancaster University United Kingdom , University Of Liverpool United Kingdom , European Federation Of Pharmaceutical Industries , Tuberculosis Foundation , Uppsala University Sweden , Innovative Medicines Initiative , University Of Hamburg Germany , Tb Alliance United States , Critical Path Institute , Critical Path Institute Ltd , University Of California San Francisco , University College London United Kingdom , European Respiratory Society Switzerland , European Union Horizon , German Federal Ministry Of Education , University Hospital Munich ,